GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
179 hedge funds and large institutions have $2.28B invested in GW Pharmaceuticals Plc American Depositary Shares in 2017 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 42 reducing their positions, and 18 closing their positions.
106% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 18
55% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 42
9% more funds holding
Funds holding: 164 → 179 (+15)
3% more capital invested
Capital invested by funds: $2.2B → $2.28B (+$76.3M)
6% less call options, than puts
Call options by funds: $112M | Put options by funds: $119M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$39M |
| 2 |
Jennison Associates
New York
|
+$38.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32.7M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$12.5M |
| 5 |
Renaissance Technologies
New York
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$61.7M |
| 2 |
Bank of New York Mellon
New York
|
-$27.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.5M |
| 4 |
Goldman Sachs
New York
|
-$25.9M |
| 5 |
Capital Fund Management (CFM)
Paris,
France
|
-$18.6M |
GWPH Hedge Fund Activity: Q1 2017 in Review
179 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2017, worth a combined $2.28B — up 3.5% from $2.2B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new GWPH positions and 18 closed out — a net gain of 19 holders — while 65 added to existing stakes and 42 trimmed.
The largest buyer was BlackRock, adding an estimated $39M. The largest seller was Deerfield Management, cutting an estimated $61.7M.
- 179 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2017, up from 164 in Q4 2016.
- Funds reported $2.28B of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2017, up 3.5% quarter-over-quarter.
- 37 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2017 and 18 closed out, a net change of +19 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2017 was BlackRock, an estimated $39M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2017 was Deerfield Management, an estimated $61.7M sold.
Based on aggregated 13F filings for Q1 2017.